Authors: | Chen, Q.; Wang, A.; Covelli, D. J.; Bhattacharjee, A.; Wang, Q.; Orth-He, E. L.; Rao, S. D.; Huang, H. C.; Ball, D. P.; Hsiao, J. C.; Bachovchin, D. A. |
Article Title: | Optimized M24B aminopeptidase inhibitors for CARD8 inflammasome activation |
Abstract: | Inflammasomes are innate immune signaling platforms that trigger pyroptotic cell death. NLRP1 and CARD8 are related human inflammasomes that detect similar danger signals, but NLRP1 has a higher activation threshold and triggers a more inflammatory form of pyroptosis. Both sense the accumulation of intracellular peptides with Xaa-Pro N-termini, but Xaa-Pro peptides on their own without a second danger signal only activate the CARD8 inflammasome. We recently reported that a dual inhibitor of the Xaa-Pro-cleaving M24B aminopeptidases PEPD and XPNPEP1 called CQ31 selectively activates the CARD8 inflammasome by inducing the build-up of Xaa-Pro peptides. Here, we performed structure-activity relationship studies on CQ31 to develop the optimized dual PEPD/XPNPEP1 inhibitor CQ80 that more effectively induces CARD8 inflammasome activation. We anticipate that CQ80 will become a valuable tool to study the basic biology and therapeutic potential of selective CARD8 inflammasome activation. © 2023 American Chemical Society. |
Keywords: | signal transduction; metabolism; neoplasm proteins; apoptosis regulatory proteins; tumor protein; apoptosis regulatory protein; caspase recruitment domain signaling protein; aminopeptidase; pyroptosis; inflammasome; card signaling adaptor proteins; inflammasomes; humans; human; aminopeptidases; card8 protein, human |
Journal Title: | Journal of Medicinal Chemistry |
Volume: | 66 |
Issue: | 4 |
ISSN: | 0022-2623 |
Publisher: | American Chemical Society |
Date Published: | 2023-02-23 |
Start Page: | 2589 |
End Page: | 2607 |
Language: | English |
DOI: | 10.1021/acs.jmedchem.2c01535 |
PUBMED: | 36724486 |
PROVIDER: | scopus |
PMCID: | PMC10149104 |
DOI/URL: | |
Notes: | Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Daniel Bachovchin -- Source: Scopus |